Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 3 studies | 18% ± 1% |
Insufficient scRNA-seq data for expression of FOXRED2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 100% | 1331.09 | 1808 / 1809 | 100% | 64.28 | 472 / 472 |
brain | 100% | 2250.11 | 2641 / 2642 | 100% | 53.24 | 704 / 705 |
prostate | 99% | 921.51 | 243 / 245 | 100% | 38.76 | 500 / 502 |
esophagus | 98% | 651.82 | 1423 / 1445 | 99% | 40.53 | 182 / 183 |
ovary | 100% | 1956.84 | 180 / 180 | 98% | 33.70 | 421 / 430 |
breast | 100% | 832.71 | 457 / 459 | 98% | 33.91 | 1099 / 1118 |
uterus | 99% | 1341.36 | 169 / 170 | 97% | 42.32 | 446 / 459 |
stomach | 98% | 656.18 | 353 / 359 | 94% | 28.46 | 270 / 286 |
intestine | 97% | 626.92 | 934 / 966 | 90% | 18.11 | 475 / 527 |
lung | 94% | 740.62 | 543 / 578 | 93% | 28.01 | 1069 / 1155 |
bladder | 100% | 959.67 | 21 / 21 | 86% | 19.23 | 431 / 504 |
adrenal gland | 100% | 1512.46 | 258 / 258 | 81% | 14.62 | 186 / 230 |
liver | 96% | 629.57 | 217 / 226 | 84% | 19.32 | 340 / 406 |
thymus | 98% | 808.07 | 641 / 653 | 66% | 10.15 | 400 / 605 |
kidney | 97% | 646.01 | 86 / 89 | 59% | 7.84 | 528 / 901 |
pancreas | 88% | 418.96 | 290 / 328 | 60% | 7.51 | 107 / 178 |
eye | 0% | 0 | 0 / 0 | 100% | 35.90 | 80 / 80 |
ureter | 0% | 0 | 0 / 0 | 100% | 19.19 | 1 / 1 |
spleen | 99% | 1241.72 | 239 / 241 | 0% | 0 | 0 / 0 |
adipose | 99% | 784.57 | 1194 / 1204 | 0% | 0 | 0 / 0 |
muscle | 99% | 732.53 | 791 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 96% | 574.70 | 1281 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 64.32 | 43 / 45 |
heart | 82% | 437.49 | 704 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 79% | 9.86 | 23 / 29 |
peripheral blood | 22% | 362.28 | 204 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0036503 | Biological process | ERAD pathway |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0004497 | Molecular function | monooxygenase activity |
GO_0050660 | Molecular function | flavin adenine dinucleotide binding |
GO_0005515 | Molecular function | protein binding |
Gene name | FOXRED2 |
Protein name | FAD dependent oxidoreductase domain containing 2 FAD-dependent oxidoreductase domain-containing protein 2 (Endoplasmic reticulum flavoprotein associated with degradation) |
Synonyms | ERFAD |
Description | FUNCTION: Probable flavoprotein which may function in endoplasmic reticulum associated degradation (ERAD). May bind non-native proteins in the endoplasmic reticulum and target them to the ubiquitination machinery for subsequent degradation. . |
Accessions | ENST00000688825.1 A0A8I5KVQ6 ENST00000692693.1 ENST00000216187.10 [Q8IWF2-1] ENST00000691242.1 A0A8I5KTD3 ENST00000397223.4 [Q8IWF2-1] ENST00000684868.1 [Q8IWF2-1] ENST00000423980.1 ENST00000686024.1 A0A8I5KZ46 A0A8I5KV30 B0QYA2 ENST00000688870.1 ENST00000685612.1 ENST00000689211.1 ENST00000685224.1 ENST00000687273.1 ENST00000397224.9 [Q8IWF2-1] Q8IWF2 |